...
首页> 外文期刊>Protein engineering design & selection: PEDS >Production of soluble pMHC-l molecules in mammalian cells using the molecular chaperone TAPBPR
【24h】

Production of soluble pMHC-l molecules in mammalian cells using the molecular chaperone TAPBPR

机译:使用分子伴随分子伴随的哺乳动物细胞中可溶性PMHC-L分子的生产

获取原文
获取原文并翻译 | 示例
           

摘要

Current approaches for generating major histocompatibility complex (MHC) Class-I proteins with desired bound peptides (pMHC-l) for research, diagnostic and therapeutic applications are limited by the inherent instability of empty MHC-I molecules. Using the properties of the chaperone TAP-binding protein related (TAPBPR), we have developed a robust method to produce soluble, peptide-receptive MHC-I molecules in Chinese Hamster Ovary cells at high yield, completely bypassing the requirement for laborious refolding from inclusion bodies expressed in E.coli. Purified MHC-I/TAPBPR complexes can be prepared for multiple human allotypes, and exhibit complex glycan modifications at the conserved Asn 86 residue. As a proof of concept, we demonstrate both HLA allele-specific peptide binding and MHC-restricted antigen recognition by T cells for two relevant tumor-associated antigens. Our system provides a facile, high-throughput approach for generating pMHC-l antigens to probe and expand TCR specificities present in polyclonal T cell repertoires.
机译:目前,利用所需结合肽(pMHC-l)生成主要组织相容性复合体(MHC)I类蛋白质用于研究、诊断和治疗应用的方法受到空MHC-I分子固有不稳定性的限制。利用分子伴侣TAP结合蛋白相关蛋白(TAPBPR)的特性,我们开发了一种在中国仓鼠卵巢细胞中高产制备可溶性肽受体MHC-I分子的稳健方法,完全绕过了大肠杆菌表达的包涵体的费力复性要求。纯化的MHC-I/TAPBPR复合物可用于多种人类同种异型,并在保守的Asn 86残基处显示出复杂的聚糖修饰。作为概念证明,我们证明了T细胞对两种相关肿瘤相关抗原的HLA等位基因特异性肽结合和MHC限制性抗原识别。我们的系统为产生pMHC-l抗原提供了一种简便、高通量的方法,以探测和扩展多克隆T细胞库中存在的TCR特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号